Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Nokia Corporation - Managers' transactions (Sahgal)
-
Nokia Corporation - Managers' transactions (Uitto)
-
Nokia Corporation - Managers' transactions (Schoeb)
-
Nokia Corporation - Managers' transactions (Guillén)
-
Nokia Corporation - Managers' transactions (Gibb)
-
Nokia Corporation - Managers' transactions (Batra)
-
Fortuna Investments Launches Women’s Sports Investment Platform
-
Bitget Fuels Blockchain Talent By Collaborating with University of Zurich
-
What is National Cheap Flight Day?
-
Parexel’s Near-Term Greenhouse Gas Reduction Targets Validated by Science Based Target Initiative (SBTi)
-
Mawson Infrastructure Group Inc. Expands into AI and HPC Markets and Announces the Signing of AI/HPC Colocation Agreement for 20 MW
-
ZOOZ Power Reports Financial Results for the Six Months Ended June 30, 2024
-
AITX's RAD Projects $10M in Guarding Cost Savings for August
-
AITX's RAD Projects $10M in Guarding Cost Savings for August
-
AB INTL GROUP Reports of Financial Results for period ending May 31, 2024 and achieved Net Profitability
-
D-Wave Quantum Inc. (NYSE: QBTS) Featured in Syndicated Broadcast Highlighting Extended Product Roadmap, Enhancements to Quantum Cloud Service
-
Envoy Medical Reports Second Quarter 2024 Results and Provides Business Update
-
Rail Vision Granted US Patent Approval on AI-Powered Railway Obstacle Detection System
-
Novo Nordisk A/S – Share repurchase programme
-
SHEIN Transformed Guests into Festival Trendsetters at VELD and îLESONIQ
-
Bird Continues to Grow Industrial Portfolio Nationally
-
Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates
-
LM Funding America, Inc. Provides Monthly Operational and Bitcoin Mining Update for Month Ended July 31, 2024; Announces LOI to Acquire a Mining Facility with 72 MW Potential
-
Star Equity Holdings Announces Investment in Enservco Corporation
-
REPEAT - KP Tissue to Release its Financial Results and those of Kruger Products Inc. for the Second Quarter of 2024
-
Atossa Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update
-
Nayax to Participate in Oppenheimer and Needham Conferences During the Week of August 12, 2024
-
Oragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required Genotoxicity Study
-
Cerevance Appoints Sagar Vaidya, M.D. Ph.D., as Chief Medical Officer
-
S&P 500 Nuclear Energy Stocks Prices Surge 800% on Largest U.S. Power Grid
-
Open Lending to Attend the Canaccord Genuity 44th Annual Growth Conference
-
Stran & Company Reports Preliminary Selected Unaudited Results for the Six Months Ended June 30, 2024
-
UDF IV Files Proxy Statement and Mails Letter to Shareholders
-
180 Degree Capital Corp. Notes Agreement With Lantronix, Inc. for Nomination of Directors at Upcoming Annual Meeting of Stockholders
-
Alarum to Release Second Quarter Results on August 26, 2024
-
DeFi Technologies Subsidiary Valour Inc. Announces Rebalancing of the Valour Digital Asset Basket 10 (VDAB10) and the STOXX Bitcoin Suisse Index
-
OptimumBank Announces New Participants at the Inaugural Virtual Banking Conference on September 12, 2024, via Live Webcast
-
Complete Solaria to Report Second Quarter Financial and Operational Results on August 14, 2024
-
Safe and Green Holdings Announces Preliminary Term Sheet to Refinance Waldron Facility
-
S&P 500 Nuclear Energy Stocks Prices Surge 800% on Largest U.S. Power Grid
-
Wave Life Sciences Receives FDA Rare Pediatric Disease Designation for WVE-N531 for the Treatment of Duchenne Muscular Dystrophy
-
Xenon Expands Leadership Team with Matthew D. Ronsheim, Ph.D. as Chief Operating Officer
-
Safety Shot Announces Powerful Data Analysis From Recent Clinical Trial Confirming Dramatic Reduction of Blood Alcohol Content
-
OMNIQ Expands AI Access Control System to an Additional Major Medical Center in Texas
-
SRM Expands Distribution with ICEE Brand Sip With Me Cups Coming Soon to a Theater Near You
-
Above Food to Participate in the 44th Annual Canaccord Genuity Growth Conference
-
ConnectM Publishes Impact Scorecard for the Six Months Ended June 30, 2024
-
Telomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher Chapman
-
CytoDyn Announces Completion of FDA Meeting on Phase II Study of Leronlimab in Patients with Relapsed/Refractory Microsatellite Stable Colorectal Cancer
-
Aprea Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
